The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications
- PMID: 34764939
- PMCID: PMC8576340
- DOI: 10.3389/fendo.2021.756581
The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications
Abstract
Diabetes mellitus and the associated complications are metabolic diseases with high morbidity that result in poor quality of health and life. The lack of diagnostic methods for early detection results in patients losing the best treatment opportunity. Oral hypoglycemics and exogenous insulin replenishment are currently the most common therapeutic strategies, which only yield temporary glycemic control rather than curing the disease and its complications. Exosomes are nanoparticles containing bioactive molecules reflecting individual physiological status, regulating metabolism, and repairing damaged tissues. They function as biomarkers of diabetes mellitus and diabetic complications. Considering that exosomes are bioactive molecules, can be obtained from body fluid, and have cell-type specificity, in this review, we highlight the multifold effects of exosomes in the pathology and therapy of diabetes mellitus and diabetic complications.
Keywords: biomarkers; diabetes mellitus; diagnosis; exosomes; mesenchymal stem cells; therapy.
Copyright © 2021 Sun, Tao, Wu, Zhang, Liu and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Exosomes and diabetes.Diabetes Metab Res Rev. 2019 Mar;35(3):e3107. doi: 10.1002/dmrr.3107. Epub 2019 Jan 7. Diabetes Metab Res Rev. 2019. PMID: 30513130 Review.
-
Exosomes for diabetes syndrome: ongoing applications and perspective.Biomater Sci. 2022 May 4;10(9):2154-2171. doi: 10.1039/d2bm00161f. Biomater Sci. 2022. PMID: 35319553 Review.
-
Exosomes derived from mesenchymal stem cells in diabetes and diabetic complications.Cell Death Dis. 2024 Apr 17;15(4):271. doi: 10.1038/s41419-024-06659-w. Cell Death Dis. 2024. PMID: 38632264 Free PMC article. Review.
-
Therapeutic Potentials of Extracellular Vesicles for the Treatment of Diabetes and Diabetic Complications.Int J Mol Sci. 2020 Jul 21;21(14):5163. doi: 10.3390/ijms21145163. Int J Mol Sci. 2020. PMID: 32708290 Free PMC article. Review.
-
Treatment and Diagnosis of Diabetes Mellitus and Its Complication: Advanced Approaches.Mini Rev Med Chem. 2015;15(14):1132-3. doi: 10.2174/138955751514151006154616. Mini Rev Med Chem. 2015. PMID: 26459815 No abstract available.
Cited by
-
Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis.Int J Mol Sci. 2024 Sep 27;25(19):10447. doi: 10.3390/ijms251910447. Int J Mol Sci. 2024. PMID: 39408777 Free PMC article.
-
Extracellular vesicle-mediated intercellular and interorgan crosstalk of pancreatic islet in health and diabetes.Front Endocrinol (Lausanne). 2023 May 25;14:1170237. doi: 10.3389/fendo.2023.1170237. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37305058 Free PMC article. Review.
-
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases.Pharmaceutics. 2025 Feb 12;17(2):238. doi: 10.3390/pharmaceutics17020238. Pharmaceutics. 2025. PMID: 40006605 Free PMC article. Review.
-
TLR2 promotes the progression of diabetes mellitus with atherosclerosis via activating NLRP3 inflammasome and MyD88/NF-κB signaling pathway.Sci Rep. 2025 May 10;15(1):16348. doi: 10.1038/s41598-025-00843-4. Sci Rep. 2025. PMID: 40348852 Free PMC article.
-
Integrative proteomic analysis reveals the potential diagnostic marker and drug target for the Type-2 diabetes mellitus.J Diabetes Metab Disord. 2025 Jan 22;24(1):55. doi: 10.1007/s40200-025-01562-3. eCollection 2025 Jun. J Diabetes Metab Disord. 2025. PMID: 39850446 Free PMC article.